Manuel Torres

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Neuropathic Pain

Spinal Cord Injury

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Pablo V Escribá, Ángel M Gil-Agudo, Joan Vidal Samsó, Judith Sánchez-Raya, Sebastián Salvador-de la Barrera, Vanesa Soto-León, Natacha León-Álvarez, Bosco Méndez Ferrer, Miguel David Membrilla-Mesa, Carolina Redondo Galán, Jesús Benito-Penalva, Antonio Montoto-Marqués, Javier Medel Rebollo, Ramiro Palazón García, Francisco Gutiérrez Henares, Marc Miralles, Manuel Torres, Ana Belén Nieto-Librero, David García Marco, Carmela Gómez, David Jimeno, Antonio Oliviero
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury. Spinal cord 62 (8) (2024)
Pablo V Escribá, Ángel M Gil-Agudo, Joan Vidal Samsó, Judith Sánchez-Raya, Sebastián Salvador-de la Barrera, Vanesa Soto-León, Natacha León-Álvarez, Bosco Méndez Ferrer, Miguel David Membrilla-Mesa, Carolina Redondo Galán, Jesús Benito-Penalva, Antonio Montoto-Marqués, Javier Medel Rebollo, Ramiro Palazón García, Francisco Gutiérrez Henares, Marc Miralles, Manuel Torres, Ana Belén Nieto-Librero, David García Marco, Carmela Gómez, David Jimeno, Antonio Oliviero
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury. Spinal cord 62 (8) (2024)
Pablo V Escribá, Ángel M Gil-Agudo, Joan Vidal Samsó, Judith Sánchez-Raya, Sebastián Salvador-de la Barrera, Vanesa Soto-León, Natacha León-Álvarez, Bosco Méndez Ferrer, Miguel David Membrilla-Mesa, Carolina Redondo Galán, Jesús Benito-Penalva, Antonio Montoto-Marqués, Javier Medel Rebollo, Ramiro Palazón García, Francisco Gutiérrez Henares, Marc Miralles, Manuel Torres, Ana Belén Nieto-Librero, David García Marco, Carmela Gómez, David Jimeno, Antonio Oliviero
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury. Spinal cord (2024)
Pablo V Escribá, Ángel M Gil-Agudo, Joan Vidal Samsó, Judith Sánchez-Raya, Sebastián Salvador-de la Barrera, Vanesa Soto-León, Natacha León-Álvarez, Bosco Méndez Ferrer, Miguel David Membrilla-Mesa, Carolina Redondo Galán, Jesús Benito-Penalva, Antonio Montoto-Marqués, Javier Medel Rebollo, Ramiro Palazón García, Francisco Gutiérrez Henares, Marc Miralles, Manuel Torres, Ana Belén Nieto-Librero, David García Marco, Carmela Gómez, David Jimeno, Antonio Oliviero
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury. Spinal cord 62 (8) (2024)
Roberto Beteta-Göbel, Marc Miralles, Javier Fernández-Díaz, Raquel Rodríguez-Lorca, Manuel Torres, Paula Fernández-García, Pablo Vicente Escribá, Victoria Lladó
HCA (2-Hydroxy-Docosahexaenoic Acid) Induces Apoptosis and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells. International journal of molecular sciences 23 (17) (2022)
Manuel Torres, Sebastià Parets, Javier Fernández-Díaz, Roberto Beteta-Göbel, Raquel Rodríguez-Lorca, Ramón Román, Victoria Lladó, Catalina Ana Rosselló, Paula Fernández-García, Pablo Vicente Escribá
Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids. Membranes 11 (12) (2021)